Masquerader: High Mobility Group Box-1 and Cancer
Open Access
- 15 May 2007
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (10), 2836-2848
- https://doi.org/10.1158/1078-0432.ccr-06-1953
Abstract
Since its identification a third of a century ago, the high-mobility group box-1 (HMGB1) protein has been linked to varied diverse cellular processes, including release from necrotic cells and secretion by activated macrophages engulfing apoptotic cells. Initially described as solely chromatin-associated, HMGB1 was additionally discovered in the cytoplasm of several types of cultured mammalian cells 6 years later. In addition to its intracellular role, HMGB1 has been identified extracellularly as a putative leaderless cytokine and differentiation factor. In the years since its discovery, HMGB1 has also been implicated in disease states, including Alzheimer's, sepsis, ischemia-reperfusion, arthritis, and cancer. In cancer, overexpression of HMGB1, particularly in conjunction with its receptor for advanced glycation end products, has been associated with the proliferation and metastasis of many tumor types, including breast, colon, melanoma, and others. This review focuses on current knowledge and speculation on the role of HMGB1 in the development of cancer, metastasis, and potential targets for therapy.Keywords
This publication has 94 references indexed in Scilit:
- Alarmin(g) news about dangerEMBO Reports, 2006
- Role of HMGB1 in apoptosis-mediated sepsis lethalityThe Journal of Experimental Medicine, 2006
- Altered Expression and Localization of Creatine Kinase B, Heterogeneous Nuclear Ribonucleoprotein F, and High Mobility Group Box 1 Protein in the Nuclear Matrix Associated with Colon CancerCancer Research, 2006
- Regulation of monocyte migration by amphoterin (HMGB1)Blood, 2004
- HMGB1 interacts differentially with members of the Rel family of transcription factorsBiochemical and Biophysical Research Communications, 2003
- Characterization of a Transcription Factor Binding Site, Specifically Activating MIA Transcription in MelanomaJournal of Investigative Dermatology, 2000
- High Affinity Binding and Overlapping Localization of Neurocan and Phosphacan/Protein-tyrosine Phosphatase-ζ/β with Tenascin-R, Amphoterin, and the Heparin-binding Growth-associated MoleculeJournal of Biological Chemistry, 1998
- Differences between some properties of acetylated and nonacetylated forms of HMG1 proteinBiochemical and Biophysical Research Communications, 1990
- Differences between HMG1 proteins isolated from normal and tumour cellsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1987
- High mobility group chromosomal proteins isolated from nuclei and cytosol of cultured hepatoma cells are similarBiochemistry, 1980